Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Fatty Liver Disease (NAFLD) is a condition characterized by the accumulation of excess fat in the liver of individuals who consume little to no alcohol. It is often associated with obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. While NAFLD itself is usually asymptomatic and benign, it can progress to Non-Alcoholic Steatohepatitis (NASH), a more severe form of the disease marked by liver inflammation and damage, which can lead to fibrosis, cirrhosis, and an increased risk of liver cancer. Early detection and management of NAFLD and NASH are crucial, involving lifestyle changes such as weight loss, a healthy diet, and regular exercise to reduce liver fat and inflammation.

FibroScan is a non-invasive medical device that measures liver stiffness to assess liver fibrosis and cirrhosis quickly and painlessly.

Address